|View printer-friendly version|
|Endo to Announce Second Quarter 2012 Financial Results on August 7, 2012|
Investors and other interested parties may call 866-510-0707 (domestic) or 617-597-5376 (international) and enter passcode 14424394. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from
A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until
Investors/Media: Blaine Davis, +1-610-459-7158; or Media: Kevin Wiggins, +1-610-459-7281; or Investors: Jonathan Neely, +1-610-459-6645
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Endo Pharmaceuticals business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.